key: cord-0916447-4mdzss9e
authors: Williamson, A.; Roberts, M. T.; Phillips, J.; Saha, R.
title: Early percutaneous tracheostomy for patients with COVID‐19
date: 2020-07-11
journal: Anaesthesia
DOI: 10.1111/anae.15197
sha: 122181ebc5ee42a2329ee6a7a9d52970df60f4e8
doc_id: 916447
cord_uid: 4mdzss9e

nan

may favour weaning via earlier tracheostomy.

We believe that, with precautions, early percutaneous tracheostomy can be safe for patients with COVID-19 and for staff, and describe our experience of 29 percutaneous tracheostomies between 19 March and 14 April 2020 at our Trust. Baseline characteristics are presented in Table 1 .

Overall, staff safety was maintained, there were no complications during any of the procedures, and sedative and vasopressor requirements decreased substantially following tracheostomy.

Potential for transmission was minimised by using full personal protective equipment for aerosol-generating procedures and a modified percutaneous technique. Finally, there was a substantial decrease in sedation and vasopressor requirements following tracheostomy.

Sedation decreased from a median of more than 10 mg.h À1 of both morphine and midazolam, or equivalent sedatives, while intubated to less than 5 mg.h À1 during each of the 5 days after tracheostomy, with 48% of patients requiring zero sedation. In addition, noradrenaline requirements decreased from 5 to 0 lg.min À1 over 5 days. In our experience, without tracheostomy these patients would have remained on higher doses of both for a longer period.

At our peak, we experienced shortages of sedatives, vasopressors and syringe drivers as we ventilated patients at 660% of our usual level 3 capacity. Early tracheostomy may preserve resources for other current and future patients during a pandemic without compromising patient or staff safety. It also facilitated earlier rehabilitative physiotherapy.

With our local neurological rehabilitation centre, we established a step-down ward to treat patients with tracheostomies, although ultimately only one patient was not decannulated before step-down.

Waiting for 14 days may avoid tracheostomy for subsequent non-survivors but it could negate the benefits outlined above. In addition, increased duration of mechanical ventilation, particularly if using anaesthetic machines, may have associated complications, such as delirium and longer-term psychological sequelae.

In summary, we found that early tracheostomy can be performed in a way that is safe and potentially beneficial for patients and healthcare staff. We suggest that decisions regarding tracheostomy for patients with COVID-19 should be based on the best interests of the patient on a case-bycase basis, whereas maintaining the safety of the healthcare team; an approach we aspire to for all of our intensive care patients.

Framework for open tracheostomy in COVID-19 patients

Multidisciplinary guidance for safe tracheostomy care during the COVID-19 pandemic: the NHS National Patient Safety Improvement Programme (NatPatSIP)

Tracheostomy: why, when, and how?